News

Please find below news from ODI Pharma AB. More stock relevant news can be found in the section "Stock Information" on the "INVESTORS" site.

Suche

ODI Pharma

25. Mai
3 Min.

ODI Pharma AB: Publication of interim report Q3 2021/2022

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2021 – March 2022. The report is available...

0 Kommentare

ODI Pharma

25. Feb.
4 Min.

Correction: ODI Pharma AB: Publication of half-year report 2021

Correction: ODI Pharma hereby discloses a revised half-year report for the period July – December 2021. In the previous report, the cost...

0 Kommentare

ODI Pharma

24. Feb.
4 Min.

ODI Pharma AB: Publication of half-year report 2021

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2021. The report is available...

0 Kommentare

ODI Pharma

13. Dez. 2021
2 Min.

Announcement from the Annual General Meeting in ODI Pharma AB (publ)

This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...

0 Kommentare

ODI Pharma

13. Dez. 2021
2 Min.

Kommuniké från årsstämma i ODI Pharma AB (publ)

Idag den 13 december 2021 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...

0 Kommentare

ODI Pharma

25. Nov. 2021
3 Min.

ODI Pharma AB: Publication of interim report for the first quarter 2021/2022

ODI Pharma AB (“ODI Pharma” or the “Company”) hereby publishes its interim report concerning the period July 2021 – September 2021. The...

0 Kommentare

ODI Pharma

18. Nov. 2021
1 Min.

ODI Pharma AB publishes the annual report for the fiscal year 2020/2021

The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...

0 Kommentare

ODI Pharma

9. Nov. 2021
4 Min.

Notice to Annual General Meeting in ODI Pharma AB (publ)

This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...

0 Kommentare

ODI Pharma

9. Nov. 2021
4 Min.

Kallelse till årsstämma i ODI Pharma AB (publ)

Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma måndagen den 13 december 2021 kl. 10.00 i bolagets lokaler...

0 Kommentare

ODI Pharma

28. Sept. 2021
2 Min.

ODI Pharma AB announces the date of official launch of kandol.

ODI Pharma AB (“ODI” or the “Company”) hereby announces that kandol., the CBD skincare product line, will be officially launched as of...

0 Kommentare

ODI Pharma

26. Aug. 2021
4 Min.

ODI Pharma AB: Publication of year-end report for the financial year 2020/2021

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the fourth quarter and financial year 1st of July 2020 –...

0 Kommentare

ODI Pharma

17. Aug. 2021
3 Min.

ODI Pharma AB approves the official launch of kandol., an exclusive CBD infused skincare line

ODI Pharma AB (“ODI Pharma” or the “Company”), a producer and representative of finished pharmaceutical cannabis and cosmetics products,...

0 Kommentare

ODI Pharma

9. Juli 2021
2 Min.

ODI Pharma AB: Flagging notification

ODI Pharma AB (“ODI Pharma”) has been informed that Mr. Niclas Kappelin has acquired 20’000 shares in ODI Pharma and exceeded the...

0 Kommentare

ODI Pharma

27. Mai 2021
4 Min.

ODI Pharma AB: Publication of interim report for the third quarter 2020/2021

ODI Pharma AB (“ODI” or “the Company”) hereby publishes its interim report concerning the period July 2020 – March 2021. The report is...

0 Kommentare

ODI Pharma

21. Apr. 2021
3 Min.

ODI Pharma: Update on progress in “Project Poland” and “Project Skin”

In January 2021 and February 2021, ODI Pharma AB (“ODI” or the “Company”) announced the decision to expand its current business with...

0 Kommentare

ODI Pharma

25. Feb. 2021
4 Min.

ODI Pharma AB: Publication of half-year report 2020

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2020. The report is available...

0 Kommentare

ODI Pharma

22. Feb. 2021
2 Min.

ODI Pharma achieves milestone towards market entry in Poland

ODI Pharma AB (“ODI” or the “Company”) announces that its subsidiary ODI Pharma Polska Sp. z o.o. has finalized documentation and filed...

0 Kommentare

ODI Pharma

14. Jan. 2021
2 Min.

ODI Pharma proceeds with its plans and launches Project Skin

ODI Pharma AB (“ODI” or “the Company”) announces that the Board of Directors has decided to expand ODI’s current business with...

0 Kommentare

ODI Pharma

14. Dez. 2020
3 Min.

Communique from the Annual General Meeting in ODI Pharma AB (publ)

This is an unofficial translation of a communique from the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish....

0 Kommentare

ODI Pharma

14. Dez. 2020
2 Min.

Kommuniké från årsstämma i ODI Pharma AB (publ)

Idag den 14 december 2020, hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...

0 Kommentare